Quantcast

Latest research Stories

2015-04-02 12:30:03

LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015" provides data on the

2015-04-02 12:30:00

LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Liposarcoma clinical

2015-04-02 12:29:49

LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Bone Metastasis Global Clinical Trials Review, H1, 2015" provides data on the Bone Metastasis

2015-04-02 12:29:36

LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Alcohol Addiction Global Clinical Trials Review, H1, 2015" provides data on the Alcohol Addiction

2015-04-02 08:26:25

LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Renal Anemia Global Clinical Trials Review, H2, 2014" provides data on the Renal Anemia clinical

2015-04-01 12:32:20

DALLAS, April 1, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Bone Metastasis Global Clinical Trials Review, H1, 2015" clinical trial market research report of 179

2015-04-01 12:31:15

In the news release, RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea, issued 01-Apr-2015

2015-04-01 08:33:18

LONDON and WILMINGTON, N.C., April 1, 2015 /PRNewswire/ -- Chiltern, a leading global CRO, has ranked third among all CROs in the 2015 CenterWatch survey of 1,900 global investigative sites.

2015-04-01 08:32:24

ROCKVILLE, Md., April 1, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") today announced that a new medical paper has been published


Word of the Day
cespitose
  • Growing in low tufty patches.
The word 'cespitose' comes from a Latin word meaning 'turf'.
Related